Skip to Content

ProAir RespiClick Approval History

FDA Approved: Yes (First approved March 31, 2015)
Brand name: ProAir RespiClick
Generic name: albuterol sulfate
Dosage form: Inhalation Powder
Company: Teva Pharmaceutical Industries Ltd.
Treatment for: Asthma

ProAir RespiClick (albuterol sulfate) is a breath-actuated, dry-powder, short-acting beta-agonist (SABA) inhaler for the relief of acute asthma symptoms.

Development History and FDA Approval Process for ProAir RespiClick

DateArticle
Apr 29, 2016Approval Teva Announces FDA Approval of ProAir RespiClick (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11
Apr  1, 2015Approval Teva Announces FDA Approval of ProAir RespiClick

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide